PuSH - Publication Server of Helmholtz Zentrum München

42 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Flannick, J.* et al.: Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 570, 71-76 (2019)
2.
Liu, J.* et al.: An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis. Nat. Commun. 10:2581 (2019)
3.
Spracklen, C.N.* et al.: Exome-derived adiponectin-associated variants implicate obesity and lipid biology. Am. J. Hum. Genet., accepted (2019)
4.
Aslibekyan, S.* et al.: Association of methylation signals with incident coronary heart disease in an epigenome-wide assessment of circulating tumor necrosis factor. JAMA Cardiol. 3, 463-472 (2018)
5.
Flannick, J.* et al.: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci. Data 5:180002 (2018)
6.
Mahajan, A.* et al.: Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559-571 (2018)
7.
Mahajan, A.* et al.: Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505-1513 (2018)
8.
Flannick, J.* et al.: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci. Data 4:170179 (2017)
9.
Manning, A.* et al.: A low-frequency inactivating Akt2 variant enriched in the Finnish population is associated with fasting insulin levels and type 2 diabetes risk. Diabetes 66, 2019-2032 (2017)
10.
Scott, R.A.* et al.: An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888-2902 (2017)
11.
Wheeler, E.* et al.: Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 14:e1002383 (2017)
12.
Fuchsberger, C.* et al.: The genetic architecture of type 2 diabetes. Nature 536, 41-47 (2016)
13.
Scott, R.A.* et al.: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Sci. Transl. Med. 8:341ra76 (2016)
14.
Walford, G.A.* et al.: Genome-wide association study of the modified Stumvoll Insulin Sensitivity Index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci. Diabetes 65, 3200-3211 (2016)
15.
Gaulton, K.J.* et al.: Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415-1425 (2015)
16.
Joshi, P.K.* et al.: Directional dominance on stature and cognition in diverse human populations. Nature 523, 459-462 (2015)
17.
Mahajan, A.* et al.: Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet. 11:e1004876 (2015)
18.
Kraja, A.T.* et al.: Pleiotropic genes for metabolic syndrome and inflammation. Mol. Genet. Metab. 112, 317-338 (2014)
19.
Dimas, A.S.* et al.: Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158-2171 (2013)
20.
Billings, L.K.* et al.: Impact of common variation in bone-related genes on type 2 diabetes and related traits. Diabetes 61, 2176-2186 (2012)